1-2 of 2
Chandan Kumar, M.Tech.
Close
Sort by
Journal Articles

Monosomy 7 and Co-Occurrent Genomic Aberrations Determine Chemotherapy Response in Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-04

Michael Castro, MD, Drew Watson, PhD, Ansu Kumar, M.Sc., Prashant Ramachandran Nair, B.Tech., Himanshu Grover, M.S., Diwyanshu Sahu, M.Sc., Subrat Mohapatra, M.Sc., Poornachandra G, B.Tech., Ashish Agarwal, B.V.Sc., Rakhi Purushothaman Suseela, B.Tech., Naga Ganesh, B.Tech., Mohammed Sauban, B.E., Chandan Kumar, M.Tech., Rahul K Raman, M.Sc., Divya Singh, M.S., Sayani Basu, M.Tech., Neelesh Lunkad, M.Tech., Nirjhar Mundkur, B.S., Michele Dundas Macpherson, B.A.Sc., Shweta Kapoor, M.Sc., Scott Howard, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-140087
Published: 2020
Journal Articles

Mechanisms of Azacitidine Chemotherapy Resistance in AML and MDS and New Therapy Options

Lubomir Minarik, MD, Leylah M. Drusbosky, PhD, Taher Abbasi, MS, MBA, Karina Vargova, MBBS, MSc, Vojtech Kulvait, PhD, Anna Jonasova, MD, Neeraj Kumar Singh, B.Tech, Chandan Kumar, M.Tech, Rakhi Purushothaman Suseela, B.Tech, Mamatha Patil, B.E, Patil Nilesh Dattatraya, M.Sc., Krishna Kumar Tiwari, B.Tech, Shireen Vali, PhD, Christopher R. Cogle, MD, Tomas Stopka, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5506.
https://doi.org/10.1182/blood-2018-99-114466
Published: 2018